Observations on the use of PH 203 and hydergine in some circulatory disturbances of the fundus and vascular retinopathy.
D000577:Amides / Q000627:therapeutic use*; D062365:Aminobenzoates / Q000627:therapeutic use*; D004088:Dihydroergotoxine; D004338:Drug Combinations; D004877:Ergoloid Mesylates; D005123:Eye / Q000098:blood supply*; D005654:Fundus Oculi; D011343:Procaine / Q000031:analogs & derivatives; D012160:Retina / Q000098:blood supply*
D000577:Amides; D062365:Aminobenzoates; D004338:Drug Combinations; C006783:dihydroergotoxin, p-aminobenzoyl-N-diethyl-leucinol drug combination; D004088:Dihydroergotoxine; D011343:Procaine; D004877:Ergoloid Mesylates
AMINOBENZOATES/therapeutic use; DIETHYLAMIDE/therapeutic use; EYE/blood supply; RETINA/blood supply